Cargando…
Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels
Introduction: As the third generation of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), osimertinib has demonstrated more significant cardiotoxicity than previous generations of EGFR-TKIs. Investigating the mechanism of osimertinib cardiotoxicity can provide a reference for a...
Autores principales: | Li, Peiwen, Tian, Xiaohui, Wang, Gongxin, Jiang, Enshe, Li, Yanming, Hao, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267729/ https://www.ncbi.nlm.nih.gov/pubmed/37324483 http://dx.doi.org/10.3389/fphar.2023.1177003 |
Ejemplares similares
-
Corrigendum: Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels
por: Li, Peiwen, et al.
Publicado: (2023) -
Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
por: Cui, Qingli, et al.
Publicado: (2022) -
Automated Electrophysiology Makes the Pace for Cardiac Ion Channel Safety Screening
por: Möller, Clemens, et al.
Publicado: (2011) -
Structures Illuminate Cardiac Ion Channel Functions in Health and in Long QT Syndrome
por: Brewer, Kathryn R., et al.
Publicado: (2020) -
Instability Mechanism of Osimertinib in Plasma and a Solving Strategy in the Pharmacokinetics Study
por: Yuan, Zheng, et al.
Publicado: (2022)